Bidda Sovereign Intelligence · 10,090 Verified Nodes · 39 Sovereign Pillars

EU Medical Devices Regulation 2017/745 - CE Marking, Clinical Evaluation & Post-Market Surveillance

EU MDR 2017/745 (fully applicable May 2021) replaces MDD/AIMDD with a risk-based classification system (Class I-III), mandatory clinical evaluation,…

What EU Medical Devices Regulation 2017/745 - CE Marking, Clinical Evaluation & Post-Market Surveillance requires

EU MDR 2017/745 (fully applicable May 2021) replaces MDD/AIMDD with a risk-based classification system (Class I-III), mandatory clinical evaluation, post-market clinical follow-up, and EUDAMED registration for all medical devices placed on the EU market - manufacturers face up to EUR 100 million product liability exposure.

Pillar: Medical & Healthcare · Authority: European Commission - DG SANTE Medical Devices · Version: 2.0 · Last updated:

Primary source: https://ec.europa.eu/health/md_sector/new_regulations/guidance_en

SHA-256 integrity: 30f5a6f28a8f3d0d735b4e178bd11c1ac75ebf6335cb15e0e6b78328296fcf57

Primary Citations — 5 traced to source

  • {"title":"EU Medical Devices Regulation 2017/745","url":"https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32017R0745"}
  • {"title":"European Commission MDR Guidance Documents","url":"https://ec.europa.eu/health/md_sector/new_regulations/guidance_en"}

+ 3 more citations (full bibliography, deterministic workflow, actionable schema and crosswalks) included in the vault unlock — $0.01 via Skyfire / L402 / Direct Base USDC.

Access

⚠ Important: Human Verification Required

Bidda compliance nodes are reference intelligence, not legal advice. Every node must be reviewed by a qualified compliance professional or legal counsel before implementation in any enterprise workflow, regulated system, or compliance programme. See bidda.com/disclaimer for full terms.